Premature Ejaculation News and Research

RSS

When a male is stimulated in a sexual manner, a signal travels from the brain to the genital area via nerves through the spinal cord. The signal is responsible for making the pelvic muscles contract rhythmically, which is how sperm is transported from the testes to the vas deferens. Extra fluid is added by the seminal vesicles and the prostate gland to protect the sperm.

Premature ejaculation drug Dapoxetine submitted for marketing in approval in Europe

Janssen-Cilag companies in Europe have submitted a Marketing Authorisation Application (MAA) for dapoxetine, a treatment for premature ejaculation (PE) in men 18-64 years of age.

10 Dec 2007

Dapoxetine for the treatment of premature ejaculation.

Premature ejaculation (PE) is defined as “persistent or recurrent onset of orgasm and ejaculation with minimal sexual stimulation before, on, or shortly after penetration and before the person wishes it.”

29 Aug 2007

Anaesthetic spray delays ejaculation by five times longer

Patients with premature ejaculation who used a topical anaesthetic spray were able to delay ejaculation for five times as long, according to a study in the February issue of the urology journal BJU International.

24 Jan 2007

New drug sorts out premature ejaculation

According the American Urological Association, premature ejaculation affects about 20% of males in the U.S. aged 18-59.

11 Sep 2006

SSRI's developed for premature ejaculation, safe and effective

A selective serotonin reuptake inhibitor (SSRI) developed specifically for the treatment of premature ejaculation is safe and effective for men severely affected by the condition, according to an Article in this week's issue of The Lancet.

7 Sep 2006

New drug for the treatment of premature ejaculation has great results

In new data published this week it has been shown that men taking dapoxetine hydrochloride for the treatment of premature ejaculation (PE) have experienced significant improvements in sexual function, including ejaculatory control, satisfaction with sexual intercourse for men and their partners, and increases in intravaginal ejaculatory latency time (IELT).

24 May 2005

First large study defining premature ejaculation by stopwatch and patient reported outcomes

In a four-week study of 1,587 men, researchers report that men who suffer from premature ejaculation (PE) had an average intravaginal ejaculatory latency time (IELT) of 1.8 minutes, compared to 7.3 minutes in men who did not. Men with PE and their female partners also had higher ratings for personal distress, interpersonal difficulty with their partner, lack of ejaculation control, and dissatisfaction with sexual intercourse.

13 Apr 2005

Simple plastic ring could help the seven million men in Britain who suffer from premature ejaculation

Dr Andy Zamar, a consultant psychiatrist at the Priory Hospital, Roehampton, Surrey, who invented the device, presented the results of a newly-published randomised controlled trial of 52 men with premature ejaculation. They were treated either with the device or cognitive behavioural therapy (CBT) at the Maudsley Hospital, South London.

10 Jul 2004

20–30 percent of men worldwide are commonly affected by premature ejaculation (PE)

It is one of man's most common, underestimated sexual problems: Ejaculating earlier than desired. More common than erectile dysfunction, this condition can affect men at any point in their lives, and one in four men experience poor control over ejaculation on a frequent basis.

12 May 2004